![](/img/cover-not-exists.png)
Does high-dose interferon beta-1b improve clinical response in more severely disabled multiple sclerosis patients?
Luca Durelli, Alessandra Oggero, Elisabetta Verdun, Gianluca Isoardo, Alessandra Ricci, Pierangelo Barbero, Bruno BergamascoVolume:
178
Year:
2000
Language:
english
DOI:
10.1016/s0022-510x(00)00361-0
File:
PDF, 57 KB
english, 2000